Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2026)
Rapid Micro Biosystems (RPID) posted FCF Margin of 188.34% for Q1 2026, down 749.94% sequentially from 22.16% in Q4 2025, and down 5810.0% YoY from 3.3% in Q1 2025.
Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported FCF Margin for 7 years, with the latest figure at 188.34% in Q1 2026.
- Quarterly FCF Margin fell 5810.0% year-over-year to 188.34% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 106.91% (up 2394.0% YoY) and the FY2025 annual result came in at 92.52%, up 6975.0% from the prior year.
- FCF Margin eased to 188.34% in Q1 2026 per RPID's latest filing, from 22.16% in the prior quarter.
- Over five years, FCF Margin peaked at 22.16% in Q4 2025 and troughed at 460.43% in Q1 2022.
- A 5-year average of 203.56% and a median of 146.57% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 22994 bps in 2022, then jumped 27827 bps in 2023.
- Over 5 years, FCF Margin stood at 126.82% in 2022, then retreated by 16 bps to 146.57% in 2023, then gained by 7 bps to 136.85% in 2024, then surged by 84 bps to 22.16% in 2025, then plunged by 750 bps to 188.34% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 188.34%, 22.16%, and 124.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.73% |
| 10 | Rapid Micro Biosystems | 80.98 Mn | 61.21 Mn | 1.21 Mn | -154.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -154.94% |
| Mar 31, 2026 | -188.34% |
| Dec 31, 2025 | -22.16% |
| Sep 30, 2025 | -124.19% |
| Jun 30, 2025 | -130.21% |
| Mar 31, 2025 | -130.24% |
| Dec 31, 2024 | -136.85% |
| Sep 30, 2024 | -113.48% |
| Jun 30, 2024 | -144.05% |
| Mar 31, 2024 | -287.11% |
| Dec 31, 2023 | -146.57% |
| Sep 30, 2023 | -157.56% |
| Jun 30, 2023 | -173.15% |
| Mar 31, 2023 | -346.47% |
| Dec 31, 2022 | -126.82% |
| Sep 30, 2022 | -435.83% |
| Jun 30, 2022 | -337.12% |
| Mar 31, 2022 | -460.43% |
| Dec 31, 2021 | -268.57% |
| Sep 30, 2021 | -290.71% |